Literature DB >> 10454063

Incidence of thyroid cancer in Scandinavia following fallout from atomic bomb testing: an analysis of birth cohorts.

E Lund1, M R Galanti.   

Abstract

OBJECTIVES: The occurrence relation between radioactive fallout from nuclear testing at Novaja Semlja in north-west Russia and the incidence of thyroid cancer in Norway and Sweden was studied following a birth cohort approach.
METHODS: Birth cohorts with presumably different levels of exposure were identified according to calendar year of atomic tests and previous Norwegian estimates of the population dose (born 1947-1950 received low exposure in late childhood, born 1951-1962 received the highest exposure in early childhood, born 1963-1970 were not exposed). For each one-year birth cohort the incidence rates were calculated, with denominators based on exact population figures for each year of follow-up.
RESULTS: In a stratified analysis, the relative risk for the highest exposed cohorts born 1951-1962, compared to those not exposed born 1963-1970, was found to decrease with increasing age from a borderline significant relative risk (RR) of 1.7 (95 percent confidence interval, 95% CI: 1.0-3.0) for children in the age-group 7-14 years to no excess risk among those 20-24 years of age (RR: 0.9; 95% CI: 0.7-1.2). The mean age at diagnosis of thyroid cancer in the age-group 7 14 years was lowest in the birth cohorts with the highest exposure. The Poisson regression analysis showed essentially the same results, with an improved fit when adding an interaction term between age and birth-cohort to a basic model with age, gender, birth-cohort and country.
CONCLUSION: These results are compatible with an increased risk of thyroid cancer during childhood and adolescence for subjects exposed to radioactive fallout early in life. Alternative explanations for the pattern of incidence are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10454063     DOI: 10.1023/a:1008815327004

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  6 in total

1.  RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.

Authors:  A K Siraj; M Al-Rasheed; M Ibrahim; K Siddiqui; F Al-Dayel; O Al-Sanea; S Uddin; K Al-Kuraya
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

2.  Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests: an update.

Authors:  Ethel S Gilbert; Lan Huang; Andre Bouville; Christine D Berg; Elaine Ron
Journal:  Radiat Res       Date:  2010-05       Impact factor: 2.841

3.  Interleukin 22 polymorphisms and papillary thyroid cancer.

Authors:  Y G Eun; I H Shin; Y C Lee; S Y Shin; S K Kim; J H Chung; K H Kwon
Journal:  J Endocrinol Invest       Date:  2013-02-27       Impact factor: 4.256

4.  A nested case-control study of polychlorinated biphenyls, organochlorine pesticides, and thyroid cancer in the Janus Serum Bank cohort.

Authors:  Catherine C Lerro; Rena R Jones; Hilde Langseth; Tom K Grimsrud; Lawrence S Engel; Andreas Sjödin; Hyoyoung Choo-Wosoba; Paul Albert; Mary H Ward
Journal:  Environ Res       Date:  2018-04-23       Impact factor: 6.498

5.  NBN Gene Polymorphisms and Cancer Susceptibility: A Systemic Review.

Authors:  Francesco Berardinelli; Alessandra di Masi; Antonio Antoccia
Journal:  Curr Genomics       Date:  2013-11       Impact factor: 2.236

6.  Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.

Authors:  Abdul K Siraj; Muna Ibrahim; Maha Al-Rasheed; Jehad Abubaker; Rong Bu; Shakaib U Siddiqui; Fouad Al-Dayel; Osama Al-Sanea; Abdulrahman Al-Nuaim; Shahab Uddin; Khawla Al-Kuraya
Journal:  BMC Med Genet       Date:  2008-07-05       Impact factor: 2.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.